A Multi-center, Randomized, Double-blind, Positive-control, Phase III Trial of the Efficacy and Safety of Clevudine.
Phase of Trial: Phase III
Latest Information Update: 26 Apr 2018
At a glance
- Drugs Clevudine (Primary) ; Adefovir
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 29 Jul 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 29 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Sep 2010 New trial record